Scilight Press

Author Information

Published: 02 Jul 2025

References 

• 1.
  Bentata, Y. Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity. Artif. Organs 2020, 44, 140–152.
• 2.
  Chen, L.; Prasad, G.R. CYP3A5 polymorphisms in renal transplant recipients: Influence on tacrolimus treatment. Pharmacogenomics Pers. Med. 2018, 11, 23–33.
• 3.
  Brunet, M.; Pastor-Anglada, M. Insights into the pharmacogenetics of tacrolimus pharmacokinetics and pharmacodynamics. Pharmaceutics 2022, 14, 1755.
• 4.
  Brunet, M.; van Gelder, T.; Åsberg, A.; et al. Therapeutic drug monitoring of tacrolimus-personalized therapy: Second consensus report. Ther. Drug Monit. 2019, 41, 261–307.
• 5.
  Kanegusuku, A.G.; Yeo, K.T. Is the automated Elecsys tacrolimus assay on the Roche cobas e 602 analyzer an acceptable replacement for a liquid chromatography-tandem mass spectrometry-based assay? Am. J. Clin. Pathol. 2024, 161, 97–106.
• 6.
  Parant, F.; Delignette, M.C.; Charpiat, B.; et al. Tacrolimus monitoring in liver transplant recipients, posttransplant cholestasis: A comparative between 2 commercial immunoassays and a liquid chromatography-tandem mass spectrometry method. Ther. Drug Monit. 2024, 46, 446–455.
• 7.
  Saitman, A.; Metushi, I.G.; Mason, D.S.; et al. Evaluation of the Waters MassTrak LC-MS/MS Assay for Tacrolimus and a Comparison to the Abbott Architect Immunoassay. Ther. Drug Monit. 2016, 38, 300–304.
• 8.
  Alabi, A.; Ge, M.; Momper, J.D.; et al. Measurement of whole blood tacrolimus concentrations by LC-MS/MS and immunoassay methods: Influence of immediate-release vs. extended-release tacrolimus formulations. J. Appl. Lab. Med. 2025, jfae156. https://doi.org/10.1093/jalm/jfae156.
• 9.
  Woodard, K.; Kisler, T.; Dasgupta, A. Good correlation between tacrolimus concentrations using improved CMIA on the Alinity i analyzer and LC-MS/MS method from a reference laboratory but unexpected negative bias with another LC-MS/MS method from a different reference laboratory. Am. J. Clin. Pathol. 2024, 162, 2–6.
• 10.
  Guerra-Martinuzzi, A.; Pampín-Conde, F.; Álvarez-Suárez, E.; et al. Puzzling interference in the Siemens tacrolimus assay in a renal transplant patient: A case report. Clin. Chim. Acta 2023, 543, 117327.
• 11.
  Christians, U.; Vinks, A.; Langman, L.J.; et al. Impact of laboratory practices on interlaboratory variability in therapeutic drug monitoring of immunosuppressive drugs. Ther. Drug Monit. 2015, 37, 718–224.